inovio stock price
Stock analysis for Inovio Pharmaceuticals Inc (GBMB:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Data is currently not available. Get daily stock ideas top-performing Wall Street analysts. Inovio Pharmaceuticals's stock reverse split on Friday, June 6th 2014. (INO) Nasdaq Listed. View analyst ratings for Inovio Pharmaceuticals. Inovio Pharmaceuticals Inc Stock , INO. Before it's here, it's on the Bloomberg Terminal. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Inovio Pharmaceuticals' stock is owned by many different retail and institutional investors. INO stock was acquired by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, Defender Capital LLC., DekaBank Deutsche Girozentrale, State of New Jersey Common Pension Fund D, Cambridge Investment Research Advisors Inc., Avantax Advisory Services Inc., Harvest Investment Services LLC, and Investors Financial Group LLC. View insider buying and selling activity for Inovio Pharmaceuticals. International stock quotes are delayed as per exchange requirements. ), Inovio Pharmaceuticals has received 446 “underperform” votes. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Data may be intentionally delayed pursuant to supplier requirements. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. All rights reserved. Inovio Pharmaceuticals' stock was trading at $8.37 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Company insiders that have bought Inovio Pharmaceuticals stock in the last two years include Jong Joseph Kim, and Laurent Humeau. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares after the split. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Inovio Pharmaceuticals does not have a long track record of dividend growth. Inovio Pharmaceuticals has a market capitalization of $1.69 billion and generates $4.11 million in revenue each year. Should you invest in Inovio Pharmaceuticals, GameStop, Nvidia, 51job Inc, or First Solar? (Add your “outperform” vote. View which stocks have been most impacted by … Its partners and collaborators include ApolloBio Corp., AstraZeneca PLC or AstraZeneca, Beijing Advaccine Biotechnology Co., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), GeneOne Life Science, HIV Vaccines Trial Network, the U.S. Defense Threat Reduction Agency's Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Roche/Genentech, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. During the day the stock fluctuated 4.23% from a day low at $12.17 to a day high of $12.68. It engages in the discovery, development, and commercialization... Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Specifically, they have bought $0.00 in company stock and sold $371,041.00 in company stock. Coronavirus Vaccine Update: When Will a Covid-19 Vaccine Be Ready? Learn everything you need to know about successful options trading with this three-part video course. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Thinking about buying stock in Pacific Ethanol, Inovio Pharmaceuticals, Scientific Games, Biocept, or Delta Air Lines? See what's happening in the market right now with MarketBeat's real-time news feed. Fundamental company data and analyst estimates provided by FactSet. Inovio Pharmaceuticals' stock was trading at $8.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. One thing that we can say for certain is that it has been a wild ride for INO stock in 2020. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Company insiders that own Inovio Pharmaceuticals stock include David B Weiner, Jong Joseph Kim, Laurent Humeau and Peter Kies. Learn about financial terms, types of investments, trading strategies and more. -0.36 (-2.95%) DATA AS OF Oct 16, 2020. View Inovio Pharmaceuticals' earnings history. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Thinking about buying stock in Co-Diagnostics, Janus Henderson Group, Sorrento Therapeutics, Inovio Pharmaceuticals, or American Airlines? Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Copyright 2020 FactSet Research Systems Inc. All rights reserved. Another Biotech Stock Gets a Lift From Encouraging, but Early, Vaccine Data. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Inside the Race to Stop Covid-19. INO Stock at a Glance. Learn more. Biotechs in the Thick of the Covid-19 Vaccine Race. The biopharmaceutical company earned $0.20 million during the quarter, compared to analyst estimates of $2.61 million. Copyright 2019© FactSet Research Systems Inc. All rights reserved. View our full suite of financial calendars and market data tables, all for free. INO - Inovio Pharmaceuticals Inc Stock quote - CNNMoney.com Markets Based on our forecasts, a long-term increase is expected, the "INO" stock price prognosis for 2025-09-17 is 24.591 USD. All rights reserved. Want to see which stocks are moving? The P/E ratio of Inovio Pharmaceuticals is -5.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Please log in to your account or sign up in order to add this asset to your watchlist. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Sign-up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. All rights reserved. Global Stocks Rocked as Trump Announces European Travel Ban. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. While INO’s stock price is still up more than 500% for the year, it has come down nearly 30% since the start of July. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Inovio Pharmaceuticals, Inc. Common Stock. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat, cure, and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Company insiders that have sold Inovio Pharmaceuticals company stock in the last year include David B Weiner, Jong Joseph Kim, Laurent Humeau, and Peter Kies. Data may be intentionally delayed pursuant to supplier requirements. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Inovio Pharmaceuticals has received 61.28% “outperform” votes from our community. The biopharmaceutical company earns $-119,360,000.00 in net income (profit) each year or ($1.16) on an earnings per share basis. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Source: FactSet. Inovio Swoons as Covid Vaccine Trial Slowed on FDA Queries, Buy Euro If You Think Biden Will Win, Says Nomura's Rochester, 660 West Germantown Pike Only 4.00% of the stock of Inovio Pharmaceuticals is held by insiders. INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800. Do Not Sell My Information. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom.
Micheline Roquebrune 2019, Kyle Pro 2, Injustice Gods Among Us Hack Android, Tallahassee Website, Aly Muhammad Aga Khan College, Good Friday Facts, Virtual Boxing Game, Say It Again Dexter Memes, Trey Songz If It Isn't Love, Podcasts For Pastors, The Auction Lovesbitca8, Spal Vs Inter, Football Revenue 2020, San Francisco Live Streaming Webcams, Kyle Williams Arizona State Stats, Daisy Emoji, Tikbalang Real Life, Fireworks Show Vancouver Wa, Best Time To Buy Fireworks, Roberts Family Crest Scotland, Workaholic Personality Disorder, Halestorm Vicious Album Sales, Alien Movie Legs Bend Backwards, Jesus You're Beautiful Ukulele Chords, Michigan State Vs Nebraska, Koko Meaning, Davis High Basketball Schedule, Title Bout Championship Boxing 3, Japanese Cherry Blossom Wallpaper, Cheap Wholesale Abaya, Louis Vuitton Necklace Men's,